Prevention of postsurgical adhesions by INTERCEED(TC7), an absorbable adhesion barrier: A prospective, randomized multicenter clinical study

S. M. Cohen, R. R. Franklin, A. F. Haney, L. R. Malinak, G. W. Patton, J. A. Rock, S. M. Rosenberg, R. W. Webster, A. A. Yuzpe

Research output: Contribution to journalArticlepeer-review

197 Scopus citations

Abstract

INTERCEED(TC7) (Johnson & Johnson Patient Care Inc., New Brunswick, NJ) is an absorbable fabric specially designed to reduce postsurgical adhesions. The authors report on a prospective, randomized, multicentEr, clinical trial that evaluated the efficacy of Interceed in reducing adhesions in humans. Infertility patients (n = 74) with bilateral pelvic sidewall adhesions were studied at treatment laparotomy and 'second-look' laparoscopy to determine Interceed's effectiveness. After removal of adhesions at laparotomy, the deperitonealized area of one pelvic sidewall was covered with Interceed. The contralateral untreated sidewall served as the control. Pelvic sidewalls covered with Interceed had a 90% improvement over control sidewalls in preventing adhesion formation. Additionally, Interceed treatment was associated with a 57% reduction of the extenT of adhesion formation over that obtained by microsurgical techniques alone. IntercEed also provided a significant benefit in reducing the severity of those adhesions that did form, and significantly reduced the number of adhesions between the ovary and pelvic sidewall. In conclusion, Interceed significantly reduced the incidence, extent, and severity of postsurgical pelvic adhesions.

Original languageBritish English
Pages (from-to)933-938
Number of pages6
JournalFertility and Sterility
Volume51
Issue number6
StatePublished - 1989

Fingerprint

Dive into the research topics of 'Prevention of postsurgical adhesions by INTERCEED(TC7), an absorbable adhesion barrier: A prospective, randomized multicenter clinical study'. Together they form a unique fingerprint.

Cite this